These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35923138)

  • 21. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
    Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
    Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy.
    Guan Q; Guo R; Huang S; Zhang F; Liu J; Wang Z; Yang X; Shuai X; Cao Z
    J Control Release; 2020 Apr; 320():392-403. PubMed ID: 32004587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
    Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
    Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors.
    Shen Z; Liu T; Li Y; Lau J; Yang Z; Fan W; Zhou Z; Shi C; Ke C; Bregadze VI; Mandal SK; Liu Y; Li Z; Xue T; Zhu G; Munasinghe J; Niu G; Wu A; Chen X
    ACS Nano; 2018 Nov; 12(11):11355-11365. PubMed ID: 30375848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System.
    Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
    Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
    Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGFB targeting biodegradable FePt alloy assembly for MRI guided starvation-enhancing chemodynamic therapy of cancer.
    Zhang C; Leng Z; Wang Y; Ran L; Qin X; Xin H; Xu X; Zhang G; Xu Z
    J Nanobiotechnology; 2022 Jun; 20(1):264. PubMed ID: 35672821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatially Asymmetric Nanoparticles for Boosting Ferroptosis in Tumor Therapy.
    Hou M; Liu M; Yu H; Kou Y; Jia J; Zhou Q; Zhang F; Zhao D; Zhao T; Li X
    Nano Lett; 2024 Jan; 24(4):1284-1293. PubMed ID: 38230643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer.
    Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H
    Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional nanolocks with GSH as the key for synergistic ferroptosis and anti-chemotherapeutic resistance.
    Zhu J; Wang X; Su Y; Shao J; Song X; Wang W; Zhong L; Gan L; Zhao Y; Dong X
    Biomaterials; 2022 Sep; 288():121704. PubMed ID: 35948496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amorphous NiB@IrO
    Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
    Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
    Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
    J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
    Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
    Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy.
    Liao Z; Wen E; Feng Y
    J Nanobiotechnology; 2024 Apr; 22(1):147. PubMed ID: 38570829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and Disulfidptosis.
    Guo S; Li Z; Zhou R; Feng J; Huang L; Ren B; Zhu J; Huang Y; Wu G; Cai H; Zhang Q; Ke Y; Guan T; Chen P; Xu Y; Yan C; Ou C; Shen Z
    Small; 2024 Jul; 20(29):e2309842. PubMed ID: 38431935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic catalysis of intratumor Fe
    Yang J; Ren B; Cai H; Xiong W; Feng J; Fan Q; Li Z; Huang L; Yan C; Li Y; Chen C; Shen Z
    Biomaterials; 2025 Feb; 313():122793. PubMed ID: 39226655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NaYF
    Chen Y; Li H; Hou B; Wu A; Wu W; Li C; Wang H; Chen D; Wang X
    Small; 2024 Jan; 20(1):e2304438. PubMed ID: 37661593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified Ferroptosis.
    Tang Q; Wang Y; Yan B; Zhang J; Wang T; Fang Y; Ye Z; Zhang N; Zhang N; Wu Z; Fan H; Lyu Y; Liu X; Wu R
    ACS Nano; 2024 Oct; 18(43):29804-29819. PubMed ID: 39431335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.